The Sacrix Sacrofuse system is uniquely innovated for the treatment of Degenerative Sacroiliitis and Sacroiliac Joint Disruption. Our sacrix technique is designed for lateral-oblique SIJ fusion with the aim for outpatient less exposure surgery treatment. The procedure is indicated for sacroiliac joint fusion for conditions Degenerative Sacroiliitis and Sacroiliac Joint Disruptions.
About Sacroiliac joint fusion technique
Sacroiliac joint dysfunction is responsible for 25% of lower back pain cases across the world. This is generally used to treat back or leg pain caused by SI joint dysfunction. Within the past few years, there has been resurgence in the recognition of the SI joint as a potential source of low back pain as treatment options for SI joint dysfunction have advanced.Numerous techniques exist for the surgical treatment of sacroiliac joint dysfunction. The main goal is to stabilize the joint by using implants and sometimes instrumentation.
About Sacrix
Sacrix is a safe direct percutaneous outpatient procedure allowing for faster recovery and same day treatment. The posterior approach is indicated for the for the treatment of sacroiliitis and sacroiliac joint disruption. This allows for direct compression and fusion of the sacroiliac joint. The Sacrix SIJ treatment is a least invasive outpatient treatment option. Sacrix is a KICVentures portfolio company
About KICVentures
KICVentures is a private investment holding company founded by Harvard-trained Orthopedic Surgeon & Professor Dr. Kingsley R. Chin, who brings unique experience at the intersection of medicine, business and information technology. KICVentures is equipped with a strong advantage in identifying niche healthcare opportunities and has a proven track-record of building the most disruptive spine technology portfolio, including AxioMed and NanoFUSE Biologics. It has headquarters in Boston, MA.http://www.KICventures.com